Cargando…

Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma

BACKGROUND: Pancreatic carcinoma (PC) is one of the most aggressive cancers affecting human health. It is essential to identify candidate biomarkers for the diagnosis and prognosis of PC. The present study aimed to investigate the diagnosis and prognosis biomarkers of PC. METHODS: Differentially exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Yang, Wang, Kunyuan, Geng, Lanlan, Sun, Jingjing, Xu, Wanfu, Liu, Dingli, Gong, Sitang, Zhu, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412825/ https://www.ncbi.nlm.nih.gov/pubmed/30639415 http://dx.doi.org/10.1016/j.ebiom.2019.01.003

Ejemplares similares

Long Noncoding RNA Expression Signatures of Colon Cancer Based on the ceRNA Network and Their Prognostic Value
por: Cheng, Yang, et al.
Publicado: (2019)

Evaluation of Monocarboxylate Transporter 4 in Inflammatory Bowel Disease and Its Potential Use as a Diagnostic Marker
por: He, Liying, et al.
Publicado: (2018)

PKN2 in colon cancer cells inhibits M2 phenotype polarization of tumor-associated macrophages via regulating DUSP6-Erk1/2 pathway
por: Cheng, Yang, et al.
Publicado: (2018)

Jatrorrhizine Suppresses Murine-Norovirus-Triggered N-GSDMD-Dependent Pyroptosis in RAW264.7 Macrophages
por: Fu, Ming, et al.
Publicado: (2023)

REC8 inhibits EMT by downregulating EGR1 in gastric cancer cells
por: Zhao, Junhong, et al.
Publicado: (2018)

Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma
por: Yang, Zongcheng, et al.
Publicado: (2019)

CD147 Aggravated Inflammatory Bowel Disease by Triggering NF-κB-Mediated Pyroptosis
por: Xu, Zhaohui, et al.
Publicado: (2020)

Identification of potential diagnostic biomarkers in MMPs for pancreatic carcinoma
por: Xie, Junhao, et al.
Publicado: (2021)

Vitronectin Destroyed Intestinal Epithelial Cell Differentiation through Activation of PDE4-Mediated Ferroptosis in Inflammatory Bowel Disease
por: Pan, Wenxu, et al.
Publicado: (2023)

A Computational Approach to Justifying Stratifin as a Candidate Diagnostic and Prognostic Biomarker for Pancreatic Cancer
por: Mogal, Md Roman, et al.
Publicado: (2022)

Identification of Candidate Biomarker ASXL2 and Its Predictive Value in Pancreatic Carcinoma
por: Wang, Gaoming, et al.
Publicado: (2021)

Identification of Candidate Biomarkers and Analysis of Prognostic Values in Oral Squamous Cell Carcinoma
por: Huang, Guang-zhao, et al.
Publicado: (2019)

Rabeprazole inhibits inflammatory reaction by inhibition of cell pyroptosis in gastric epithelial cells
por: Xie, Jing, et al.
Publicado: (2021)

Helicobacter pylori promotes gastric intestinal metaplasia through activation of IRF3-mediated kynurenine pathway
por: Liang, Xinhua, et al.
Publicado: (2023)

The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma
por: Kang, Weiting, et al.
Publicado: (2020)

Identification of NUTF2 as a Candidate Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Head and Neck Squamous Cell Carcinoma
por: Zhang, Rui, et al.
Publicado: (2021)

Identification of potential pathogenic candidates or diagnostic biomarkers in papillary thyroid carcinoma using expression and methylation profiles
por: Wei, Songfeng, et al.
Publicado: (2019)

Identification and in vitro validation of diagnostic and prognostic biomarkers for lung squamous cell carcinoma
por: Zhao, Xiaopeng, et al.
Publicado: (2022)

MiR-1 suppresses tumor cell proliferation in colorectal cancer by inhibition of Smad3-mediated tumor glycolysis
por: Xu, Wanfu, et al.
Publicado: (2017)

Corrigendum to “The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma”
por: Kang, Weiting, et al.
Publicado: (2020)

Identifying Diagnostic and Prognostic Biomarkers and Candidate Therapeutic Drugs of Gastric Cancer Based on Transcriptomics and Single-Cell Sequencing
por: Zhao, Xu, et al.
Publicado: (2021)

Identification of Family with Sequence Similarity 110 Member C (FAM110C) as a Candidate Diagnostic and Prognostic Biomarker for Glioma
por: Ren, Deshuai, et al.
Publicado: (2023)

LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma
por: Yang, Chunxiu, et al.
Publicado: (2021)

miR-34a induces neutrophil apoptosis by regulating Cdc42-WASP-Arp2/3 pathway-mediated F-actin remodeling and ROS production
por: Cao, Meiwan, et al.
Publicado: (2022)

Identification of LOX as a candidate prognostic biomarker in Glioblastoma multiforme
por: Liu, Erheng, et al.
Publicado: (2023)

Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma
por: Li, Jingyuan, et al.
Publicado: (2020)

Identification and Validation of a Diagnostic and Prognostic Multi-Gene Biomarker Panel for Pancreatic Ductal Adenocarcinoma
por: Klett, Hagen, et al.
Publicado: (2018)

Identification of novel candidate biomarkers for pancreatic adenocarcinoma based on TCGA cohort
por: Jie, Yang, et al.
Publicado: (2021)

AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma
por: Ma, Chenxi, et al.
Publicado: (2020)

Identification of diagnostic and prognostic biomarkers, and candidate targeted agents for hepatitis B virus-associated early stage hepatocellular carcinoma based on RNA-sequencing data
por: Zeng, Zhili, et al.
Publicado: (2020)

Identification of Candidate Biomarkers and Prognostic Analysis in Colorectal Cancer Liver Metastases
por: Zhang, Tianhao, et al.
Publicado: (2021)

Identification of Hub Diagnostic Biomarkers and Candidate Therapeutic Drugs in Heart Failure
por: Guo, Yang, et al.
Publicado: (2022)

A novel strategy to identify candidate diagnostic and prognostic biomarkers for gastric cancer
por: Liu, Lei, et al.
Publicado: (2021)

Role of TFRC as a Novel Prognostic Biomarker and in Immunotherapy for Pancreatic Carcinoma
por: Yang, Cheng, et al.
Publicado: (2022)

Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer
por: Khomiak, Andrii, et al.
Publicado: (2020)

Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma
por: Wang, Jihan, et al.
Publicado: (2021)

Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma
por: Zuo, Duo, et al.
Publicado: (2022)

Key Candidate Prognostic Biomarkers Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Deng, Zenghua, et al.
Publicado: (2021)

Identification of potential diagnostic and prognostic biomarkers for prostate cancer
por: Zhang, Qiang, et al.
Publicado: (2019)

Identification of Novel Biomarker Candidates for the Immunohistochemical Diagnosis of Cholangiocellular Carcinoma
por: Padden, Juliet, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_o8f9bcov5q44gav35hhjqpiu1p